Götte M - Search Results

1

Aberrant expression of the pluripotency marker SOX-2 in endometriosis.

Götte M, Wolf M, Staebler A, Buchweitz O, Kiesel L, Schüring AN. Götte M, et al. Fertil Steril. 2011 Jan;95(1):338-41. doi: 10.1016/j.fertnstert.2010.08.006. Epub 2010 Sep 20. Fertil Steril. 2011. PMID: 20850729 Free article.

2

Overexpression of Endothelin-A-receptor in breast cancer: regulation by estradiol and cobalt-chloride induced hypoxia.

Wülfing P, Götte M, Sonntag B, Kersting C, Schmidt H, Wülfing C, Buerger H, Greb R, Böcker W, Kiesel L. Wülfing P, et al. Among authors: gotte m. Int J Oncol. 2005 Apr;26(4):951-60. Int J Oncol. 2005. PMID: 15753989

3

Metformin alters insulin signaling and viability of human granulosa cells.

Sonntag B, Götte M, Wülfing P, Schüring AN, Kiesel L, Greb RR. Sonntag B, et al. Among authors: gotte m. Fertil Steril. 2005 Oct;84 Suppl 2:1173-9. doi: 10.1016/j.fertnstert.2005.04.043. Fertil Steril. 2005. PMID: 16210009 Free article.

4

Defective glycosylation of decorin and biglycan, altered collagen structure, and abnormal phenotype of the skin fibroblasts of an Ehlers-Danlos syndrome patient carrying the novel Arg270Cys substitution in galactosyltransferase I (beta4GalT-7).

Seidler DG, Faiyaz-Ul-Haque M, Hansen U, Yip GW, Zaidi SH, Teebi AS, Kiesel L, Götte M. Seidler DG, et al. Among authors: gotte m. J Mol Med (Berl). 2006 Jul;84(7):583-94. doi: 10.1007/s00109-006-0046-4. Epub 2006 Apr 1. J Mol Med (Berl). 2006. PMID: 16583246

5

Predictive value of syndecan-1 expression for the response to neoadjuvant chemotherapy of primary breast cancer.

Götte M, Kersting C, Ruggiero M, Tio J, Tulusan AH, Kiesel L, Wülfing P. Götte M, et al. Anticancer Res. 2006 Jan-Feb;26(1B):621-7. Anticancer Res. 2006. PMID: 16739330 Free article. Clinical Trial.

6

Expression and prognostic impact of the protein tyrosine phosphatases PRL-1, PRL-2, and PRL-3 in breast cancer.

Radke I, Götte M, Kersting C, Mattsson B, Kiesel L, Wülfing P. Radke I, et al. Among authors: gotte m. Br J Cancer. 2006 Aug 7;95(3):347-54. doi: 10.1038/sj.bjc.6603261. Epub 2006 Jul 11. Br J Cancer. 2006. PMID: 16832410 Free PMC article.

7

An expression signature of syndecan-1 (CD138), E-cadherin and c-met is associated with factors of angiogenesis and lymphangiogenesis in ductal breast carcinoma in situ.

Götte M, Kersting C, Radke I, Kiesel L, Wülfing P. Götte M, et al. Breast Cancer Res. 2007;9(1):R8. doi: 10.1186/bcr1641. Breast Cancer Res. 2007. PMID: 17244359 Free PMC article.

8

On the role of endothelin-converting enzyme-1 (ECE-1) and neprilysin in human breast cancer.

Smollich M, Götte M, Yip GW, Yong ES, Kersting C, Fischgräbe J, Radke I, Kiesel L, Wülfing P. Smollich M, et al. Among authors: gotte m. Breast Cancer Res Treat. 2007 Dec;106(3):361-9. doi: 10.1007/s10549-007-9516-9. Epub 2007 Feb 13. Breast Cancer Res Treat. 2007. PMID: 17295044

9

Endocytosis of the dermatan sulfate proteoglycan decorin utilizes multiple pathways and is modulated by epidermal growth factor receptor signaling.

Feugaing DD, Tammi R, Echtermeyer FG, Stenmark H, Kresse H, Smollich M, Schönherr E, Kiesel L, Götte M. Feugaing DD, et al. Among authors: gotte m. Biochimie. 2007 May;89(5):637-57. doi: 10.1016/j.biochi.2006.12.012. Epub 2007 Jan 21. Biochimie. 2007. PMID: 17335953

10

Selective ETAR antagonist atrasentan inhibits hypoxia-induced breast cancer cell invasion.

Smollich M, Götte M, Kersting C, Fischgräbe J, Kiesel L, Wülfing P. Smollich M, et al. Among authors: gotte m. Breast Cancer Res Treat. 2008 Mar;108(2):175-82. doi: 10.1007/s10549-007-9589-5. Epub 2007 Apr 28. Breast Cancer Res Treat. 2008. PMID: 17468950

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

544 results

Search Page

Filters